Brief: Cynata Therapeutics Enters At-Market Subscription Agreement With Acuity Capital
22/08/2025 03:01
Aug 22 (Reuters) - Cynata Therapeutics Ltd CYP.AX: ENTERED INTO AN AT--MARKET SUBSCRIPTION AGREEMENT WITH ACUITY CAPITAL DEAL PROVIDES CO WITH UP TO A$7.5 MILLION OF STANDBY EQUITY CAPITAL OVER COMING 5 YEARS Further company coverage: CYP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million